Sector ratings Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Equities

End-of-day quote Shanghai S.E. Other stock markets 2026-01-23			5-day change	1st Jan Change
58.99 ^CNY	-0.76%		-4.76%	-0.97%

Jan. 22	Hengrui Pharmaceuticals' Subsidiaries Get Nod to Trial Two Tumor Drugs	MT
Jan. 20	Hengrui Pharmaceuticals' Unit Gets Nod to Trial Diabetes Drugs	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	56.71B		AA
ELI LILLY AND COMPANY	974B		A
JOHNSON & JOHNSON	526B		BBB
ABBVIE INC.	385B		AA
ROCHE HOLDING AG	376B		AA
ASTRAZENECA PLC	284B		A
NOVARTIS AG	279B		AAA
NOVO NORDISK A/S	277B		A
MERCK & CO., INC.	271B		A
AMGEN INC.	187B		A
GILEAD SCIENCES, INC.	163B		AAA
PFIZER INC.	148B		BBB
VERTEX PHARMACEUTICALS INCORPORATED	119B		AA
SANOFI	113B		A
BRISTOL-MYERS SQUIBB COMPANY	112B		A
GSK PLC	97.69B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	87.31B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
BAYER AG	50.98B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	50.15B		AA
Average	231.05B		AA
Weighted average by Cap.			AA